A review of the clinical evidence related to early treatment of elevated LDL for cardiovascular primary prevention.
作者信息
Sauser Kori, Levine Deborah A, Hayward Rodney A
机构信息
Department of Emergency Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA Center for Clinical Management Research, Ann Arbor Veterans Affairs Hospital, Ann Arbor, Michigan, USA.
出版信息
Evid Based Med. 2015 Oct;20(5):162-9. doi: 10.1136/ebmed-2015-110170. Epub 2015 Jul 14.
PMID:26173413
Abstract
摘要
相似文献
1
A review of the clinical evidence related to early treatment of elevated LDL for cardiovascular primary prevention.
Evid Based Med. 2015 Oct;20(5):162-9. doi: 10.1136/ebmed-2015-110170. Epub 2015 Jul 14.
2
Treating elevated LDL cholesterol in patients with low short-term risk: Decision making at the limits of EBM.
Evid Based Med. 2015 Oct;20(5):151-3. doi: 10.1136/ebmed-2015-110257. Epub 2015 Sep 16.
3
Appropriate clinical use of statins: a discussion of the evidence, scope, benefits, and risk.
Altern Ther Health Med. 2013;19 Suppl 1:14-25.
4
Altering the pathophysiology of atherosclerosis: the multidimensional role of statins.
J Am Osteopath Assoc. 2010 Apr;110(4 Suppl 4):S2-6.
5
Targeting low-density lipoprotein cholesterol in cardiovascular health.
J Am Osteopath Assoc. 2010 Apr;110(4 Suppl 4):Sii-S1.
6
Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
Arch Cardiovasc Dis. 2014 Mar;107(3):188-200. doi: 10.1016/j.acvd.2014.01.011. Epub 2014 Mar 7.
7
Statin therapy in primary CVD prevention remains a hot-button topic for some.
JAMA. 2011 Nov 16;306(19):2077-8. doi: 10.1001/jama.2011.1664.
8
Lipid lowering for primary prevention.
Lancet. 2009 Apr 4;373(9670):1152-5. doi: 10.1016/S0140-6736(09)60357-3.
9
Is cholesterol lowering with statins the gold standard for treating patients with cardiovascular risk and disease?
South Med J. 2003 Mar;96(3):220-2. doi: 10.1097/01.smj.0000051743.83926.12.
10
[JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].
Lakartidningen. 2009;106(21-22):1471-5.
引用本文的文献
1
Legacy effects of statins on cardiovascular and all-cause mortality: a meta-analysis.
BMJ Open. 2018 Oct 4;8(9):e020584. doi: 10.1136/bmjopen-2017-020584.
2
When to Start a Statin Is a Preference-Sensitive Decision.
Circulation. 2017 Sep 19;136(12):1099-1101. doi: 10.1161/CIRCULATIONAHA.117.029808.
3
Population Impact & Efficiency of Benefit-Targeted Versus Risk-Targeted Statin Prescribing for Primary Prevention of Cardiovascular Disease.
J Am Heart Assoc. 2017 Feb 10;6(2):e004316. doi: 10.1161/JAHA.116.004316.
Zotero 插件